• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu17Asp (c.51A>T); Zygosity=Unspecified (PubMed=7819056).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys24Asn (c.72A>T); Zygosity=Unspecified (PubMed=7819056).
  

PubMed=6579923; DOI=10.1111/j.1447-0756.1983.tb00638.x
Suzumori K., Sugimoto Y., Suzjmori K., Yagami Y., Takeda A.
The establishment of human choriocarcinoma cell line in vitro.
Asia Oceania J. Obstet. Gynaecol. 9:309-315(1983)

PubMed=6682628; DOI=10.1016/0002-9378(83)90927-4
Sekiya S., Kaiho T., Shirotake S., Iwasawa H., Takeda B., Takamizawa H.
Effect of methotrexate on the growth and human chorionic gonadotropin secretion of human choriocarcinoma cell lines in vitro.
Am. J. Obstet. Gynecol. 146:57-64(1983)

PubMed=2878840; DOI=10.1016/0020-7292(86)90088-3
Yamashita K., Nakamura T., Shimizu T., Katagiri M., Ikeda H.
Expression of HLA class I and class II antigens in human choriocarcinoma cell lines.
Int. J. Gynaecol. Obstet. 24:301-307(1986)

PubMed=7819056; DOI=10.1038/bjc.1995.3; PMCID=PMC2033447
Yaginuma Y., Yamashita T., Takuma N., Katayama H., Ishikawa M.
Analysis of the p53 gene in human choriocarcinoma cell lines.
Br. J. Cancer 71:9-12(1995)

DOI=10.1007/0-306-46861-1_8
Ganapathy V., Prasad P.D., Leibach F.H.
Choriocarcinoma.
(In book chapter) Human cell culture. Vol. 2. Cancer cell lines part 2; Masters J.R.W., Palsson B.O. (eds.); pp.141-147; Kluwer Academic Publishers; New York; USA (1999)

PubMed=11014955; DOI=10.1159/000010310
Takayanagi T., Aoki Y., Tanaka K.
Expression of constitutively active c-MET receptor in human choriocarcinoma.
Gynecol. Obstet. Invest. 50:198-202(2000)